Regular ArticlesA prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results
Keywords
Cited by (0)
- f1
Address correspondence to: Dr George Torrance, 1016-A Sutton Drive, Suite 200, Burlington, ON, Canada L7L 6B8. Tel: (905) 331 9911; Fax: (905) 331 9912; E-mail: [email protected]
- f2
The Canadian Knee OA Study Group included the Steering Committee and clinical investigators. The Steering Committee consisted of J. P. Raynauld and G. W. Torrance, co-principal investigators; N. Bellamy, C. H. Goldsmith and P. Tugwell, co-investigators; P. A. Band, M. Schultz and V. Walker. The clinical investigators were: M. J. Bell, MD, Department of Medicine, University of Toronto, Toronto, ON; R. B. Bourne, MD, Department of Surgery, University of Western Ontario, London, ON; R. Cloutier, MD, Departement D'Orthopedie, Centre Hospitalier Affillie, Quebec, QC; A. M. Crawford, MB, Department of Medicine, University of Calgary, Calgary, AB; J. G. Cinats, Department of Surgery, University of Alberta Hospitals, Capital Health Regional Health Authority, Edmonton, AB; M.-A. Fitzcharles, MD, Department of Medicine, McGill University, Montreal, QC; R. D. Inman, MD, Division of Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON; K. W. Marshall, MD, Division of Orthopaedics, Toronto Western Hospital, University of Toronto, Toronto, ON; D. P. O'Hanlon, MB, Department of Rheumatology, University of British Columbia, North Vancouver, BC; W. P. Olszynski, MD, Department of Medicine, University of Saskatchewan, Saskatoon, SK; J. Pope, MD, Department of Medicine, University of Western Ontario, London, ON; J.-P. Raynauld, MD, Department of Medicine, University of Montreal, QC; E. D. Sutton, MD, Department of Medicine, Dalhousie University, Halifax, NS; J. C. Thorne, MD, Department of Internal Medicine and Rheumatology, York County Hospital, Newmarket, ON.